Pb1763: a phase 1/2 study to evaluate ponatinib with chemotherapy in pediatric patients with relapsed/resistant/intolerant philadelphia chromosome–positive acute lymphoblastic leukemia or with t315i mutation
HemaSphere（2022）
关键词
relapsed/resistant/intolerant philadelphia chromosome–positive,acute lymphoblastic leukemia,ponatinib,chemotherapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要